Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Deciphera Pharmaceuticals Inc (NQ: DCPH )

44.31 USD UNCHANGED
Streaming Delayed Price Updated: 4:28 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 44.31
Bid (Size) 40.77 (6)
Ask (Size) 46.69 (2)
Prev. Close 44.31
Today's Range 44.31 - 44.31
52wk Range 33.10 - 68.40
Shares Outstanding 36,894,128
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare... 
From Business Wire News Releases
Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global... 
From Business Wire News Releases

Performance

YTD
-21.89%
-21.89%
1 Month
-3.38%
-3.38%
3 Month
-26.20%
-26.20%
6 Month
-2.31%
-2.31%
1 Year
-22.29%
-22.29%

More News

Read More
Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results
From Business Wire News Releases
Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day
From Business Wire News Releases
Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on February 9, 2021
From Business Wire News Releases
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones
From Business Wire News Releases
Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
Recap: Deciphera Pharmaceuticals Q4 Earnings
Tags Market News DCPH Benzinga
From Benzinga
Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor
From Business Wire News Releases
Deciphera Pharmaceuticals, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
From Business Wire News Releases
The Boston Globe Names Deciphera a Top Place to Work for 2020
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.